Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/OCUMENSION-THERAPEUTICS-111325380/news/Ocumension-Therapeutics-Announces-Second-Phase-III-Clinical-Trial-of-OT-301-Approved-in-China-33493655/?utm_source=whatsapp&utm_medium=social&utm_campaign=share